Nostrum Says Nearly 30 Potential Buyers Have Signed NDAs
Drugmaker Nostrum Laboratories told a New Jersey bankruptcy judge Tuesday that close to 30 parties are weighing bids for the company's assets, with the debtor planning to choose a stalking horse...To view the full article, register now.
Already a subscriber? Click here to view full article